Skip to main content
See every side of every news story
Published • loading... • Updated

Ozempic Is Renewed: a New Dose for Adults with Type 2 Diabetes Arrives in Spain

Summary by laprovincia.es
The pharmaceutical company Novo has announced that it is already available in Spain, under medical prescription and funded by the National Health System, a new presentation of Ozempic (subcutaneous saemaglutide) of 2 mg weekly for the treatment of adults with type 2 diabetes mellitus. The new presentation provides a reduction of up to 2.2% in glycated hemoglobin (HbA1c) -a blood test that measures the average glucose (sugar) in the blood during …
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

4 Articles

elcorreogallego.eselcorreogallego.es
+2 Reposted by 2 other sources

The pharmaceutical company Novo has announced that it is already available in Spain, under medical prescription and funded by the National Health System, a new presentation of Ozempic (subcutaneous saemaglutide) of 2 mg weekly for the treatment of adults with type 2 diabetes mellitus. The new presentation provides a reduction of up to 2.2% in glycated hemoglobin (HbA1c) -a blood test that measures the average glucose (sugar) in the blood during …

The Spanish subsidiary of the Danish multinational Novo has been approved for funding by the National Health System of Ozempic -subcutaneous semaglutide - at the dose of 2 mg under medical prescription for the treatment of adults with type 2 diabetes. According to the company's sources, the new presentation -which doubles the higher dose financed so far for this indication - provides a reduction of up to 2.2% in glycated haemoglobin (HbA1c), as …

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

diariomedico.com broke the news on Wednesday, November 18, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal